Clinical Trial Update: A Trial to Evaluate the Effect of Rosuvastatin on Inflammation in Patients Undergoing Isolated Cardiac Valve Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial assessing rosuvastatin's effect on inflammation in patients undergoing isolated valvular cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Valvular Cardiac Surgery-related Inflammation
• Valvular Heart Disease

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Valvular Cardiac Surgery | Phase 3 | Status: COMPLETED